Phibro Animal Health (NASDAQ:PAHC) Shares Gap Up Following Earnings Beat

Key Points

• Phibro Animal Health's shares rose significantly after the company reported better-than-expected earnings, with an EPS of $0.57 compared to the consensus estimate of $0.52.
• The company declared a quarterly dividend of $0.12 per share, which represents an annualized dividend of $0.48 and a yield of 1.3%.
• Institutional investors hold a substantial 99.34% of Phibro Animal Health's stock, with notable increases in holdings by several financial firms in recent quarters.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s share price gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $32.20, but opened at $37.91. Phibro Animal Health shares last traded at $35.96, with a volume of 246,588 shares trading hands.

The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.52 by $0.05. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The firm had revenue of $378.70 million for the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.3%. Phibro Animal Health's payout ratio is presently 61.54%.

Analyst Ratings Changes

Several research analysts have recently issued reports on PAHC shares. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a research note on Monday, June 16th. Finally, JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their target price for the company from $25.00 to $35.00 in a research note on Monday, July 7th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of "Reduce" and an average target price of $24.40.

Institutional Investors Weigh In On Phibro Animal Health

Large investors have recently made changes to their positions in the stock. Financial Management Professionals Inc. acquired a new stake in Phibro Animal Health in the second quarter valued at $32,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Phibro Animal Health during the 4th quarter valued at approximately $29,000. National Bank of Canada FI bought a new stake in shares of Phibro Animal Health during the 1st quarter valued at approximately $30,000. Lazard Asset Management LLC grew its holdings in shares of Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after purchasing an additional 1,589 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company's stock worth $69,000 after buying an additional 2,685 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Trading Up 12.6%

The firm's 50-day moving average is $28.78 and its 200 day moving average is $24.29. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 46.53, a P/E/G ratio of 0.55 and a beta of 0.80.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.